Mersana Therapeutics, Inc. (MRSN)

NASDAQ: MRSN · IEX Real-Time Price · USD

1.860

-0.110 (-5.58%)

At close: Jul 2, 2024, 4:00 PM

1.900

+0.040 (2.15%)

After-hours: Jul 2, 2024, 4:37 PM EDT

Mersana Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Revenue	36.86	26.58	0.04	0.83	42.12	Upgrade
Revenue Growth (YoY)	38.65%	61716.28%	-94.81%	-98.03%	297.61%	Upgrade
Gross Profit	36.86	26.58	0.04	0.83	42.12	Upgrade
Selling, General & Admin	59.54	56.96	36.89	21.9	17.28	Upgrade
Research & Development	148.27	173.39	132.01	67.04	55.04	Upgrade
Other Operating Expenses	8.71	0	0	0	0	Upgrade
Operating Expenses	216.53	230.35	168.9	88.94	72.32	Upgrade
Operating Income	-179.67	-203.77	-168.86	-88.11	-30.2	Upgrade
Interest Expense / Income	4.07	3.33	1.27	0.36	0.23	Upgrade
Other Expense / Income	-12.07	-2.88	-0.07	-0.42	-2.23	Upgrade
Pretax Income	-171.67	-204.21	-170.06	-88.05	-28.21	Upgrade
Net Income	-171.67	-204.21	-170.06	-88.05	-28.21	Upgrade
Shares Outstanding (Basic)	116	94	71	61	43	Upgrade
Shares Outstanding (Diluted)	116	94	71	61	43	Upgrade
Shares Change	23.98%	32.69%	14.79%	41.37%	88.83%	Upgrade
EPS (Basic)	-1.48	-2.18	-2.41	-1.43	-0.65	Upgrade
EPS (Diluted)	-1.48	-2.18	-2.41	-1.43	-0.65	Upgrade
Free Cash Flow	-171.05	-51.56	-140.64	-75.17	-68.35	Upgrade
Free Cash Flow Per Share	-1.47	-0.55	-1.99	-1.22	-1.57	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-487.51%	-766.59%	-392693.02%	-10641.30%	-71.69%	Upgrade
Profit Margin	-465.80%	-768.26%	-395488.37%	-10633.45%	-66.97%	Upgrade
Free Cash Flow Margin	-464.12%	-193.97%	-327060.47%	-9078.38%	-162.26%	Upgrade
EBITDA	-163.3	-197.18	-166.11	-86.68	-26.73	Upgrade
EBITDA Margin	-443.09%	-741.81%	-386300.00%	-10468.12%	-63.45%	Upgrade
Depreciation & Amortization	4.3	3.7	2.68	1.01	1.25	Upgrade
EBIT	-167.6	-200.88	-168.79	-87.69	-27.97	Upgrade
EBIT Margin	-454.75%	-755.74%	-392541.86%	-10590.10%	-66.41%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).